We are live on
!
Find out more
GLRA
Gerald L. Ray & Associates Portfolio holdings
AUM
$802M
1-Year Est. Return
21.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.9%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$447M
AUM Growth
–
Cap. Flow
+$452M
Cap. Flow
% of AUM
101.18%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
260
New
260
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$16.4M |
| 2 |
CELG
Celgene Corp
CELG
|
+$16.3M |
| 3 |
Amgen
AMGN
|
+$12.9M |
| 4 |
Southwest Airlines
LUV
|
+$12.3M |
| 5 |
Apple
AAPL
|
+$10.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.33% |
| 2 | Consumer Staples | 13.46% |
| 3 | Industrials | 12.37% |
| 4 | Energy | 9.97% |
| 5 | Technology | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Aflac
AFL
$65.9B
| $324K | 0.07% |
+11,168
| New | +$303K |
|
202
iShares MSCI EAFE ETF
EFA
$76.8B
| $322K | 0.07% |
+5,619
| New | +$340K |
|
203
HSBC
HSBC
$356B
| $322K | 0.07% |
+7,197
| New | +$337K |
|
204
Vanguard Small-Cap Value ETF
VBR
$37.7B
| $320K | 0.07% |
+3,818
| New | +$317K |
|
205
McDonald's
MCD
$194B
| $315K | 0.07% |
+3,180
| New | +$318K |
|
206
Target
TGT
$65.5B
| $313K | 0.07% |
+4,541
| New | +$316K |
|
207
J&J Snack Foods
JJSF
$1.49B
| $311K | 0.07% |
+4,000
| New | +$303K |
|
208
iShares Latin America 40 ETF
ILF
$3.79B
| $304K | 0.07% |
+8,282
| New | +$341K |
|
|
SBR
209
Sabine Royalty Trust
SBR
$1.07B
| $300K | 0.07% |
+5,800
| New | +$297K |
|
210
NOV
NOV
$7.11B
| $296K | 0.07% |
+4,769
| New | +$294K |
|
211
iShares US Home Construction ETF
ITB
$2.41B
| $292K | 0.07% |
+13,050
| New | +$312K |
|
|
RDS.A
212
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $289K | 0.06% |
+4,538
| New | +$300K |
|
213
F5
FFIV
$22.8B
| $287K | 0.06% |
+4,170
| New | +$321K |
|
214
Scholastic
SCHL
$766M
| $287K | 0.06% |
+9,800
| New | +$277K |
|
215
Vanguard Financials ETF
VFH
$13.6B
| $287K | 0.06% |
+7,200
| New | +$285K |
|
216
WisdomTree India Earnings Fund ETF
EPI
$2.05B
| $286K | 0.06% |
+17,650
| New | +$314K |
|
|
IMVP
217
Invesco India ETF
IMVP
$125M
| $286K | 0.06% |
+17,280
| New | +$307K |
|
|
QVCGA
218
DELISTED
QVC Group Inc Series A
QVCGA
| $281K | 0.06% |
+297
| New | +$268K |
|
219
BancFirst
BANF
$3.89B
| $279K | 0.06% |
+12,000
| New | +$257K |
|
220
Union Pacific
UNP
$175B
| $279K | 0.06% |
+3,614
| New | +$272K |
|
221
iShares Silver Trust
SLV
$27.6B
| $276K | 0.06% |
+14,555
| New | +$326K |
|
222
National Grid
NGG
$81.3B
| $272K | 0.06% |
+4,980
| New | +$291K |
|
223
Sarepta Therapeutics
SRPT
$1.63B
| $272K | 0.06% |
+7,150
| New | +$256K |
|
224
Cleveland-Cliffs
CLF
$6.84B
| $265K | 0.06% |
+16,306
| New | +$312K |
|
225
Entergy
ETR
$52.4B
| $264K | 0.06% |
+7,586
| New | +$261K |
|
Similar funds
KRC
GS
PAAMCP
B
JPCCM
NBC
NTC
SD
Gerald L. Ray & Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Gerald L. Ray & Associates, which disclosed 260 positions worth $447M. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Industrials.
- Gerald L. Ray & Associates's largest Q2 2013 buy was Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
- Gerald L. Ray & Associates's ten largest holdings make up 25% of its $447M portfolio in Q2 2013.
- Gerald L. Ray & Associates disclosed 260 positions in Q2 2013, its first 13F filing on record.
Based on Gerald L. Ray & Associates's 13F filing for Q2 2013, filed 1 Aug 2013.